Early Life Exposure to Common Plastic Chemical Linked to Adult Anxiety in Rats

Chicago, Illinois – Male rats exposed to di-(2-ethylhexyl) phthalate (DEHP), a ubiquitous plasticizer found in numerous everyday products, during critical early developmental periods exhibited heightened levels of anxiety in adulthood, according to groundbreaking research presented at ENDO 2026, the Endocrine Society’s annual meeting. The findings, emerging from the University of Buenos Aires School of Medicine, suggest a potential long-term impact of endocrine-disrupting chemicals (EDCs) on behavior, raising concerns for human health.

The study, presented by Osvaldo Juan Ponzo, M.D., Ph.D., professor of physiology at the University of Buenos Aires School of Medicine, demonstrated that prenatal and immediate postnatal exposure to DEHP could instigate lasting behavioral alterations. "This research demonstrates that one of the most widely used plasticizers worldwide is capable of causing behavioral changes when the subject is exposed during the prenatal and immediate postnatal developmental stages, with this effect lasting over time," Dr. Ponzo stated. This revelation underscores the vulnerability of developing organisms to environmental contaminants and the potential for subtle, yet significant, neuroendocrine shifts.

Understanding Di-(2-ethylhexyl) Phthalate (DEHP)

DEHP is a chemical compound belonging to the phthalate family, widely employed as a plasticizer to enhance the flexibility, durability, and longevity of polyvinyl chloride (PVC) plastics. Its pervasive presence in consumer goods has made it a subject of intense scientific scrutiny due to its endocrine-disrupting properties. DEHP is a common additive in a vast array of products that people encounter daily, including medical devices such as IV bags and tubing, children’s toys, shower curtains, raincoats, and flooring.

The mechanism by which DEHP exerts its effects is thought to involve its ability to mimic or interfere with natural hormones, particularly sex hormones like testosterone and estrogen. Previous research has established that DEHP and its metabolites can disrupt multiple organ systems in both animal models and humans, with significant implications for the reproductive and nervous systems. The University of Buenos Aires researchers specifically focused on the potential link between early DEHP exposure and anxiety-related behaviors, investigating the roles of gamma-aminobutyric acid (GABA), a key inhibitory neurotransmitter in the brain, and testosterone in mediating these effects.

The Chronology of the Study and Experimental Design

The research initiative commenced with a carefully controlled experimental design aimed at isolating the impact of early-life DEHP exposure. Pregnant female rats were administered daily oral doses of DEHP, initiating on the first day of gestation and continuing uninterrupted until their offspring were weaned. This crucial period of exposure was chosen to mimic the critical windows of development where hormonal and neurological systems are particularly susceptible to environmental influences.

Following the weaning process, the male rat pups were allowed to mature. The researchers then selected a cohort of male offspring that had reached adulthood, specifically at 70 days of age, for behavioral assessment. This developmental stage was chosen to evaluate the long-term consequences of early-life exposure, independent of any potential direct exposure during adulthood.

Assessing Anxiety Through Behavioral Paradigms

To quantify anxiety-related behavior in the adult male rats, the researchers employed a well-established behavioral test known as the elevated plus maze (EPM). The EPM is a widely used rodent model for assessing anxiety, capitalizing on the innate neophobic tendencies of rodents, which naturally avoid open, elevated spaces. The maze itself is constructed in the shape of a cross, featuring two enclosed arms (providing a sense of security) and two open arms extending from a central platform.

The experimental protocol involved placing each rat individually in the center of the maze. The researchers meticulously recorded and analyzed several key behavioral metrics:

• Arm Entry Frequency: The number of times each rat ventured into the open arms versus the enclosed arms.
• Time Spent in Each Arm: The duration each rat spent exploring or residing within the open arms compared to the enclosed arms.
• Freezing Time: The amount of time a rat remained completely immobile. Freezing behavior in rodents is often interpreted as a sign of fear or anxiety in stressful situations.

Rats exhibiting higher levels of anxiety are expected to spend less time in the exposed, perceptually threatening open arms and more time in the sheltered enclosed arms. They are also likely to exhibit increased freezing behavior as a defensive response to the perceived danger.

Unraveling the Neuroendocrine Mechanisms: GABA and Testosterone

A critical component of the study involved investigating potential neurochemical pathways that might underpin the observed behavioral changes. To this end, specific interventions were implemented prior to the EPM testing. A subset of the DEHP-exposed rats received treatments designed to modulate the GABAergic system and androgen levels.

• GABA Agonists: Ninety minutes before being placed in the EPM, some rats were administered GABA agonists. These are molecules that bind to and activate GABA receptors, thereby enhancing the inhibitory neurotransmission mediated by GABA. A robust GABAergic system is crucial for regulating neuronal excitability and promoting calmness.
• Testosterone Treatment: Other DEHP-exposed rats received exogenous testosterone. This treatment involved administering testosterone every 48 hours for a period of 14 days leading up to the anxiety testing. Testosterone is a primary male sex hormone known to influence a wide range of physiological and behavioral processes, including mood and anxiety.

The rationale behind these interventions was to determine if the anxiety-inducing effects of early DEHP exposure could be reversed or mitigated by restoring normal GABAergic function or androgen levels, respectively.

Key Findings: Anxiety Manifestations and Reversal

The results of the study provided clear evidence of the impact of early DEHP exposure. Male rats that had been exposed to DEHP during their prenatal and early postnatal development, and received no further exposure in adulthood, displayed significant signs of increased anxiety when assessed in the elevated plus maze. Specifically, these rats:

• Reduced exploration of open arms: They ventured into the open arms of the maze less frequently and spent significantly less time exploring these areas.
• Increased time in enclosed arms: Conversely, they spent more time seeking refuge in the enclosed arms.
• Elevated freezing behavior: They exhibited a marked increase in freezing time, indicative of heightened fear and stress responses.

Crucially, the study also revealed the potential for reversal of these anxiety-related behaviors through targeted neuroendocrine interventions. The DEHP-exposed rats that were treated with either GABA agonists or testosterone demonstrated a starkly different behavioral profile in the EPM. These animals showed a pattern of behavior that was diametrically opposed to that of the untreated DEHP-exposed group. They were more inclined to explore the open arms, spent more time in these areas, and displayed reduced freezing behavior.

"This work demonstrates that contact with DEHP in the early stages of life could modify behavior with regard to anxiety, even in the absence of DEHP exposure in adulthood," Dr. Ponzo emphasized. "These neuroendocrine changes can be reversed by treating with GABA agonists or testosterone." This finding is particularly significant as it suggests that the effects of early-life EDC exposure are not necessarily permanent and may be amenable to therapeutic intervention.

Broader Implications and Potential for Human Impact

While this study was conducted in rodent models, the implications for human health are substantial and warrant serious consideration. Endocrine-disrupting chemicals, including phthalates like DEHP, are widespread environmental contaminants to which humans, especially developing fetuses and infants, are routinely exposed. The findings from this research align with a growing body of evidence suggesting that early-life exposure to EDCs can have profound and lasting effects on neurodevelopment and behavior.

The fact that DEHP exposure during prenatal and early postnatal development led to persistent anxiety in adult rats highlights the critical importance of the early developmental windows. During these periods, the brain is undergoing rapid differentiation, synaptogenesis, and hormonal programming. Disruption of these delicate processes by exogenous chemicals can lead to alterations in neural circuits and neurotransmitter systems that persist throughout life.

The observed role of GABA and testosterone in both mediating and reversing the anxiety effects provides valuable insight into the underlying biological mechanisms. GABA is the primary inhibitory neurotransmitter in the central nervous system, playing a crucial role in regulating arousal, anxiety, and fear responses. Imbalances in the GABAergic system have been implicated in various anxiety disorders. Testosterone, while often associated with masculinization, also influences brain function and behavior, including mood regulation. Early exposure to EDCs like DEHP may disrupt the normal development and function of these neuroendocrine systems, leading to a predisposition to anxiety.

The potential for reversal through GABA agonists and testosterone treatment offers a glimmer of hope. It suggests that interventions aimed at restoring normal GABAergic signaling or androgen balance could potentially mitigate the adverse behavioral consequences of early EDC exposure in humans. However, it is crucial to note that the translation of these findings from animal models to humans requires further rigorous investigation. Human studies are needed to confirm these associations and to explore potential therapeutic strategies.

Regulatory and Public Health Perspectives

The widespread use of DEHP and its presence in numerous consumer products raise significant public health concerns. Regulatory bodies worldwide are increasingly scrutinizing the safety of EDCs and implementing measures to limit human exposure. The findings presented at ENDO 2026 provide further scientific impetus for such regulatory actions.

Organizations such as the Environmental Protection Agency (EPA) in the United States and the European Chemicals Agency (ECHA) in Europe are actively involved in assessing the risks posed by phthalates and other EDCs. The continued research into the long-term behavioral effects of these chemicals is vital for informing risk assessments and developing effective strategies for protecting vulnerable populations.

Experts in toxicology and environmental health have expressed the need for a precautionary approach when it comes to EDC exposure, particularly during pregnancy and early childhood. This includes advocating for the use of safer alternatives in consumer products and medical devices, as well as raising public awareness about the potential risks associated with certain chemicals.

Future Directions for Research

The research presented by Dr. Ponzo and his colleagues opens several avenues for future investigation. Further studies are needed to:

• Elucidate the precise molecular mechanisms: A deeper understanding of how DEHP interacts with cellular receptors and signaling pathways in the developing brain is essential.
• Investigate other behavioral endpoints: Beyond anxiety, it would be valuable to explore whether early DEHP exposure also influences other aspects of behavior, such as learning, memory, social interaction, and aggression.
• Examine the effects of combined exposures: Humans are rarely exposed to single chemicals in isolation. Research into the effects of combined exposures to DEHP and other EDCs is critical.
• Explore sex-specific effects: While this study focused on male rats, it is important to investigate whether similar effects occur in female offspring and if there are sex-specific differences in susceptibility and response.
• Conduct human epidemiological studies: Longitudinal studies that track individuals from early development through adulthood, assessing EDC exposure levels and behavioral outcomes, are crucial for confirming the relevance of these findings to human populations.

The ENDO 2026 meeting, by providing a platform for the dissemination of such vital research, plays a crucial role in advancing scientific understanding and driving progress towards a healthier environment for all. The ongoing dialogue between researchers, policymakers, and the public will be essential in addressing the complex challenges posed by endocrine-disrupting chemicals.